VVUS
VVUS Articles
Jon OggThese are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls this Thursday. Alkermes PLC (NASDAQ: ALKS) raised to Outperform with $24 target...
Published:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
The three major U.S. stock indexes opened higher this morning, encouraged by a report from Europe that Spain was close to unveiling a rescue plan for the country’s banks that it would release next...
Published:
Last Updated:
Photo by Spencer Platt/Getty ImagesThe stock market is up Friday, with the Dow Jones Industrial Average up 0.33%, the Nasdaq up 0.59% and the S&P 500 up 0.43%. Today’s winners include a...
Published:
Last Updated:
U.S. drugmaker Vivus Inc. (NASDAQ: VVUS) announced this morning that the company had been notified that its anti-obesity drug, Qsiva, is not likely to be approved for use in the European Union. The...
Published:
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Published:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Published:
The three major US stock indexes opened higher this morning on a report from Europe that German chancellor Angela Merkel now backs bond buying by the European Central Bank.Even a larger-than-expected...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) raised to Buy at Lazard. American Tower...
Published:
Last Updated:
The three major US stock indexes opened modestly lower this morning as there was little news out of Europe and Asian markets closed mixed. Traders were waiting to hear more from Fed Chairman Bernanke...
Published:
Last Updated:
As investors brace for Wednesday’s congressional testimony from Federal Reserve Chairman Ben Bernanke, the stock market is up modestly. The Dow Jones Industrial Average is up 0.38%, the Nasdaq is...
Published:
Last Updated:
The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 to just under $26.46 at yesterday’s...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. American Tower Corp. (NYSE: AMT): Cut to Neutral at Citigroup....
Published:
Last Updated: